In addition, EA treatment prevented nuclear translocation of NF-κB p65 and suppressed expression of p38 MAPK and myeloid differentiation factor 88 (MyD88) in the peri-infract sensorimotor cortex during ischemic stroke (Liu et al., 2016a). Here, MYD88 is linked to ischemic stroke.